Dealing with renin-angiotensin inhibitors, don't mind serum creatinine

American Journal of Nephrology

Volumn 36, Issue 5, 2012, Pages 427-429

  Ruggenenti, Piero ^a,b   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; PROTEIN;

AFRICAN AMERICAN; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CAPILLARY PRESSURE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG DOSE TITRATION; EDITORIAL; FOLLOW UP; GENDER; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; KIDNEY FAILURE; MAXIMUM TOLERATED DOSE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; SODIUM DEPLETION; ULTRAFILTRATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DIURETICS; FEMALE; HUMANS; HYPERTENSION; MALE; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84868219246     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000343455     Document Type: Editorial

References (10)

1. Apperloo AJ, de Zeeuw D, de Jong PE: A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 1997; 51: 793-797.
2. Anderson S, Brenner BM: Progressive renal disease: a disorder of adaptation. Q J Med 1989; 70: 185-189.
3. Bakris GL, Weir MR: Angiotensin-convert-ing enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000; 160:685-693.
4. National Kidney Foundation I: Guideline 1: Goals of antihypertensive therapy in CKD. Am J Kidney Dis 2004; 43: S183-S218.
5. Hirsch S, Hirsch J, Bhatt U, Rovin BH: Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success. Am J Nephrol 2012; 36: 430-437.
6. Vegter S, Perna A, Postma MJ, Navis G, Re-muzzi G, Ruggenenti P: Sodium intake, ace inhibition, and progression to ESRD. J Am Soc Nephrol 2012; 23: 165-173.
7. Ruggenenti P, Perticucci E, Cravedi P, Gam-bara V, Costantini M, Sharma SK, Perna A, Remuzzi G: Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 2008; 19: 1213-1224.
8. Ruggenenti P, Remuzzi G: Proteinuria: Is the ONTARGET renal substudy actually off target? Nat Rev Nephrol 2009; 5:436-437.
9. Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Parving HH: Increased glomeru-lar filtration rate after withdrawal of longterm antihypertensive treatment in diabetic nephropathy. Kidney Int 1995; 47:1726-1731.
10. Ruggenenti P, Porrini EL, Gaspari F, Motterlini N, Cannata A, Carrara F, Cella C, Ferrari S, Stucchi N, Parvanova A, Iliev I, Dode-sini AR, Trevisan R, Bossi A, Zaletel J, Re-muzzi G: Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care 2012; 35: 2061-2068.